Herbalife Nutrition Ltd.

Herbalife Nutrition Ltd. (HLF) Market Cap

Herbalife Nutrition Ltd. has a market capitalization of $1.72B.

Financials based on reported quarter end 2025-12-31

Price: $16.65

-0.33 (-1.94%)

Market Cap: 1.72B

NYSE · time unavailable

CEO: Stephan Paulo Gratziani

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 2004-12-16

Website: https://www.herbalife.com

Herbalife Nutrition Ltd. (HLF) - Company Information

Market Cap: 1.72B · Sector: Consumer Defensive

Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Analyst Sentiment

69%
Buy

Based on 25 ratings

Analyst 1Y Forecast: $16.00

Average target (based on 3 sources)

Consensus Price Target

Low

$13

Median

$15

High

$20

Average

$16

Downside: -3.9%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HERBALIFE LTD (HLF) — Investment Overview

🧩 Business Model Overview

Herbalife Ltd operates as a global nutrition company centered on the development, marketing, and sale of science-based nutritional supplements, weight management products, energy, fitness offerings, and personal care items. The company employs a direct-selling, multi-level marketing (MLM) model, enabling independent distributors to market its products primarily outside traditional retail channels. Herbalife’s business is built on the concept of kinetic, individually owned micro-businesses propelled by a network effect, where individuals earn income directly from sales and through building and mentoring downline teams. The company’s operations are diversified geographically, spanning more than 90 countries, and cater to a wide demographic seeking nutrition, wellness, and weight management solutions.

💰 Revenue Streams & Monetisation Model

Herbalife generates revenue through the sale of consumable nutrition and personal care products to end-users. Its monetisation model is based on a structured distributor network, where products are sold at a wholesale rate to independent distributors, who then sell them either directly to retail customers or to other downline distributors. Income opportunities for distributors include retail profits, commissions, and various performance-based bonuses, which are funded by product sales volume. Revenue streams are diversified across product categories: - **Weight Management:** Meal replacement shakes, drink mixes, and supplements provide a foundation for recurring revenue. - **Targeted Nutrition:** Specialized supplements support specific health needs (e.g., heart health, digestive support, immune function). - **Energy & Fitness:** Pre-workout, hydration, and protein offerings increasingly contribute to top-line growth. - **Personal Care:** Skincare, haircare, and outer nutrition products complement the internal product portfolio. Distributor purchases drive the core revenue engine, supported by local and regional events, training, and ongoing product innovation.

🧠 Competitive Advantages & Market Positioning

Herbalife’s competitive positioning is a function of robust global scale, brand recognition in the wellness sector, and a large, motivated distributor base. Key competitive advantages include: - **Scale and Reach:** Herbalife’s sprawling international network of independent distributors enables rapid market penetration, nimble adaptation to local conditions, and efficient logistics. - **Honor Economy and Incentive Structure:** The compensation plan creates significant incentives for entrepreneurial distributors to grow sales and recruit, amplifying market presence with limited company expenditure on fixed sales infrastructure. - **Science-Driven Product Innovation:** The company invests in nutrition science and product R&D, fostering customer trust and loyalty. - **Community Engagement:** Distributor-organized nutrition clubs, community outreach, and wellness events embed Herbalife at a grassroots level. - **Asset-Light Model:** Reliance on independent distributors reduces the need for capital-intensive retail infrastructure and supports higher potential operating leverage. The result is a business with entry barriers based on community networks, consumer trust, and scale advantages that challenge new entrants.

🚀 Multi-Year Growth Drivers

Herbalife’s expansion is underpinned by secular trends and corporate initiatives: - **Global Health and Wellness Trends:** Rising health consciousness, the proliferation of diets and fitness regimens, and increased prioritization of active lifestyles support category growth worldwide. - **Penetration in Emerging Markets:** As disposable incomes rise and awareness of health increases in developing economies, Herbalife’s replicable distribution model provides a blueprint for scalable expansion. - **Product Portfolio Innovation:** Ongoing R&D enables the launch and promotion of new SKUs (e.g., plant-based proteins, functional beverages) to capture shifting consumer preferences. - **Digital Transformation:** Technology investments in digital tools and mobile platforms enhance distributor productivity, customer engagement, and retention. - **Consumer Behavior Shifts:** Increased emphasis on direct-to-consumer sales, personalized experiences, and home-based entrepreneurship plays to the strengths of the MLM framework. Together, these drivers enable multi-level opportunities for both organic growth within existing markets and geographic expansion into new territories.

⚠ Risk Factors to Monitor

Herbalife faces several key risks typical to MLM and consumer products businesses: - **Regulatory Scrutiny:** The direct-selling model is subject to variable global regulations regarding MLM, advertising, and claims about product efficacy. Heightened regulatory attention can lead to legal expenses, restrictions, or operational changes, particularly in major markets. - **Distributor Retention/Saturation:** The model relies on continued recruitment and activity. High turnover or market saturation impacts revenue and profitability. - **Reputational Risks:** Perceptions of “pyramid scheme” dynamics can damage the brand, even when legal standards are met. Negative media or legal findings can erode distributor motivation and consumer trust. - **Intense Competition:** The nutritional supplement and personal care industry is highly fragmented, with competition from global multinationals, niche brands, and digital-first entrants. - **Foreign Exchange and Geopolitical Risks:** With significant emerging market exposure, revenue and margins are subject to FX volatility and local political or economic instability. - **Litigation & Class Actions:** Legal exposure related to product claims, distributor disputes, and business practices can represent ongoing operational risk. Mitigating these risks requires rigorous internal controls, compliance, transparent communications, and proactive engagement with regulatory bodies and distributors.

📊 Valuation & Market View

Herbalife is generally evaluated against other global nutrition and consumer health companies, with market participants considering metrics such as revenue growth, EBITDA margins, free cash flow conversion, leverage ratios, and return on invested capital. The business model’s recurring revenue, achieved via a large base of repeat distributor and consumer customers, provides some defensiveness and visibility to cash flows. However, equity valuations can reflect a risk premium for regulatory uncertainty and structural sensitivity to distributor momentum. Valuation methodologies include price-to-earnings, EV/EBITDA, and price-to-free cash flow comparisons versus peers and historical ranges. Additionally, market sentiment is materially influenced by regulatory developments and channel health, beyond pure financial performance.

🔍 Investment Takeaway

Herbalife Ltd represents exposure to the long-term growth of the global nutrition and wellness industry, with a distinctive, scalable, and capital-efficient direct-selling business model. Its competitive positioning is underpinned by a vast distributor network, ongoing product innovation, and adaptability to international markets. At the same time, investors must weigh the material risks, notably around regulatory, reputational, and channel sustainability matters. The company’s future value creation depends on its ability to navigate regulatory headwinds, maintain distributor engagement, and continue driving product relevance in a dynamic, highly competitive sector. For investors seeking tailored exposure to global health and nutrition trends—balanced against elevated oversight and channel execution risks—Herbalife presents a unique, though complex, opportunity.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Headline results for HLF (latest quarter ended 2025-12-31): Revenue of $1.283B and net income of $85.4M (EPS $0.83). QoQ, revenue rose modestly (+0.72% from $1.274B) while net income nearly doubled (+97.8% from $43.2M), lifting net margin to ~6.65% (from ~3.39% in the prior quarter). YoY, revenue grew +6.28% versus 2024-12-31, but net income fell -52.0% (from $177.9M), implying profitability remains volatile year-over-year. Over the 4-quarter span, margins improved sequentially across 2025 (net margin moved from ~4.12% in 2025-03-31 to ~6.65% in 2025-12-31), but remain well below the unusually high 2024-12-31 level (~14.74%). On balance sheet resilience, HLF’s equity is still negative but has improved to -$509M from -$801M a year ago, while total assets edged up and net debt was slightly lower YoY (~$1.99B vs ~$2.05B). Shareholder returns have been exceptional: the stock is up +172.8% over 1 year, with no dividend yield reported (0%). Valuation appears stretched versus consensus targets (target ~$15–$16 vs price $17.02). Overall, momentum is strong, but earnings sustainability and margin normalization are key watch items."

Revenue Growth

Positive

Revenue increased +0.72% QoQ (Dec vs Sep 2025) and +6.28% YoY (Dec 2025 vs Dec 2024), showing steady top-line momentum despite quarter-to-quarter variability.

Profitability

Fair

Net margin improved sequentially to ~6.65% in 2025-12-31 (from ~3.39% in 2025-09-30), but YoY net income declined -52.0% (net income $85.4M vs $177.9M), indicating profitability is still inconsistent.

Cash Flow Quality

Neutral

Net income improved sharply QoQ (+97.8%), supporting earnings quality in the latest quarter; however, no explicit cash flow details are provided and YoY earnings are down, so durability is uncertain. No dividend payments reported (dividend yield 0%).

Leverage & Balance Sheet

Positive

Total equity remains negative but improved to -$509M from -$801M a year ago, while net debt is slightly lower YoY (~$1.99B vs ~$2.05B). This suggests modest strengthening but continued balance-sheet pressure.

Shareholder Returns

Strong

Total shareholder return strength is driven by capital appreciation: +172.8% 1-year change (well above the >20% momentum threshold). Dividend contribution is 0% per provided data, so buy-side momentum is the primary driver.

Analyst Sentiment & Valuation

Fair

Consensus target ($15–$16) is below the current price ($17.02), implying limited upside (~-6% to -12%). Despite low reported P/E in the latest quarter, valuation support may be sensitive to the earnings volatility seen YoY.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management sounded confident in the prepared remarks: Q4 net sales beat the high end of guidance (+6.3% YoY) and Adjusted EBITDA ($156M) exceeded guidance, while the leverage ratio stepped down to 2.8x. However, Q&A revealed specific “under-the-hood” drags embedded in 2026. The most concrete is India GST mechanics: despite the consumer GST cut boosting volume, distributor/service GST remained 18%, creating an estimated ~$16M incremental net cost between G&A and member comp in 2026. Management also quantified that margins ex-GST would be ~30 bps higher than guidance—i.e., the guide bakes in a percentage drag from GST. On Pro2col, the tone was more cautious than bullish: there’s “very little” top-line built in for 2026 because beta is an acclimation/build phase, with upside framed as vertical adoption rather than near-term volume. Analysts pressed for guidance/margin flexibility; management’s answer shifted to ex-GST normalization and execution cadence rather than a clear upside revision.

AI IconGrowth Catalysts

  • MultiBurn weight management launch (July 2025) supporting category momentum
  • HL/Skin launch in EMEA (September 2025)
  • Life I/O Baseline expansion into healthy lifespan (December 2025)
  • Sports/category momentum continues (sports outpaced overall company in 2025; sports launched in India)
  • Pro2col Beta 2.0 release (December 2025) with distributor marketing pages + coach dashboard enhancements

Business Development

  • Cristiano Ronaldo acquired a 10% equity stake in HBL Pro2col Software (subsidiary holding Pro2col technology); $7.5 million investment plus services and sponsorship rights

AI IconFinancial Highlights

  • Q4 net sales: $1.3B, +6.3% YoY; exceeded high end of guidance range (1.5% to 5.5%)
  • Q4 Adjusted EBITDA: $156M, above guidance high ($144M to $154M); Adjusted EBITDA margin 12.2%, down 20 bps YoY
  • Q4 Adjusted net income: $48M; Adjusted diluted EPS: $0.45 (includes $0.07 FX headwind)
  • Q4 gross margin: 77.5%, down 30 bps YoY; FX headwinds ~100 bps, sales mix ~30 bps, input cost inflation ~30 bps partially offset by pricing benefits ~80 bps
  • Tax: Q4 adjusted effective tax rate 34.7% (down from 40.6%); full-year 2025 adjusted effective tax rate 29.1% vs expectation 27% to 28%
  • Capital structure: leverage ratio 2.8x (down from 3.9x end of 2023); repaid $283M debt in 2025; repaid $30M debt in Q4 and increased cash by ~$50M

AI IconCapital Funding

  • Cash at quarter end: $353M (up nearly $50M QoQ)
  • Debt actions: repaid $25M on revolving credit facility (as of Sept 30) in the quarter; revolver undrawn at Dec 31; scheduled $5M term loan amortization payment
  • 2025: repaid $283M total debt; over last 2 years paid down >$530M debt
  • Management commitment: reduce gross debt to $1.4B by end of 2028

AI IconStrategy & Ops

  • Pro2col phased beta rollout: Pro2col Beta 2.0 released in December 2025; beta expanded to U.S., Canada, Puerto Rico; extending to select EMEA markets in 2026; personalized supplements rollout to initial Pro2col beta group expected by end of 1H 2026
  • Distributor support: ongoing training/digital tool enhancements; key account management program referenced for leadership retention support
  • Events/distributor engagement: management expects event costs to go up in 2026 (explicitly stated: 'expected to go up next year'; not a material change overall), with regional drivers (India Extravaganzas increases; Asia Pacific moved to 2 Extravaganzas from 1)

AI IconMarket Outlook

  • Q1 2026 (reported): net sales growth 3% to 7% YoY; includes ~250 bps currency tailwind; constant currency 0.5% to 4.5%
  • Q1 2026 Adjusted EBITDA: $155M to $175M
  • Full-year 2026 (reported): net sales growth 1% to 6% YoY; includes ~100 bps currency tailwind; constant currency flat to up 5%
  • Full-year 2026 Adjusted EBITDA: $670M to $710M (reported) or $665M to $705M (constant currency)
  • Tariffs: 2026 guidance includes preliminary estimate of tariffs enacted through 'yesterday'; currently expected to be immaterial

AI IconRisks & Headwinds

  • India GST complexity (SG&A drag vs top-line): while GST rate on most products lowered 18% to 5% drove volume (supports India record quarter), distributor/service and intercompany services GST rate remained at 18%; management guided for a net incremental cost of about $16M between G&A and member comp in 2026 (negative bottom-line impact).
  • Margin impact clarification: excluding GST, margins ex-GST expected to be ~30 bps higher than what is reflected in guidance (i.e., GST headwind reduces margin % vs underlying).
  • China: management expects China to be more of a 2027 event; 2026 expected net sales growth in every region except China.
  • Q4 profitability pressures: FX headwinds ~100 bps and employee bonus accrual headwind ~90 bps in Q4 (partially offset by pricing benefits).
  • Sustained execution hurdle: Pro2col is beta-phase with 'very little' top-line built into 2026; uncertainty tied to adoption/acclimation rather than immediate volume contribution.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HLF Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (HLF)

© 2026 Stock Market Info — Herbalife Nutrition Ltd. (HLF) Financial Profile